Literature DB >> 15349762

Urinary excretion of calcium and phosphate in preterm infants.

Narendra Aladangady1, Pietro G Coen, Madeleine P White, Margaret D Rae, T James Beattie.   

Abstract

The aims of this study were to determine reference ranges for the urinary calcium (UCa/Cr) and phosphate (UPO(4)/Cr) creatinine ratios and to study factors influencing these ratios in a representative population of preterm infants managed according to current nutritional guidelines. Spot urine samples were obtained from 186 preterm infants (gestation 24-34 weeks) for measurement of UCa/Cr and UPO(4)/Cr ratios as part of a routine metabolic bone screening program, once every 2-4 weeks from the 3rd to the 18th week of life. Data were also collected on gender, appropriate or small for gestational age (SGA), nutrition [total parenteral nutrition (TPN), preterm or term formula, and breast milk], plasma Ca, P0(4), urea, and electrolytes and on the use of drugs (frusemide, dexamethasone, and theophylline). Data from infants treated with any of these three drugs were analyzed separately and not included in establishing the reference ranges for UCa/Cr and UPO(4)/Cr. The mean gestational age of the study population was 28 weeks (range 24-34 weeks). The 95th percentile for UCa/Cr at 3 weeks of age was 3.8 mmol/mmol and decreased significantly with increasing postnatal age (P<0.001). The 95th per-centile for UPO(4)/Cr was 26.69 mmol/mmol at 3 weeks of age, but this did not change significantly with increasing postnatal age (P=0.296). On univariate analysis there was no significant association of UCa/Cr and UPO(4)/Cr with gender and type of enteral nutrition. The UCa/Cr was lower in infants who were SGA (P=0.013) and with low plasma Ca (P=0.008). Infants on TPN had significantly higher UCa/Cr (P =0.019) and lower UPO(4)/Cr ratios(P<0.001). Multivariate analysis confirmed the decrease in UCa/Cr ratio with increasing postnatal age, but the SGA effect was eliminated. The use of furosemide(P<0.001) and theophylline (P=0.003) was associated with a significant increase in the UCa/Cr ratio. The use of dexamethasone was also associated with an increase in UCa/Cr ratio, but this did not achieve statistical significance (P=0.339). The use of furosemide, theophylline,and dexamethasone had no effect on UPO(4)/Cr. We report a reference range for UCa/Cr and UPO(4)/Cr ratios and factors influencing these ratios in a representative population of preterm infants between 24 and 34 weeks gestation, managed according to current nutritional guide-lines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15349762     DOI: 10.1007/s00467-004-1574-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  37 in total

1.  Assessment of calcium excretion from the urinary calcium/creatinine ratio.

Authors:  B E NORDIN
Journal:  Lancet       Date:  1959-09-19       Impact factor: 79.321

2.  Nephrocalcinosis and phosphate supplementation in a preterm infant.

Authors:  A Short; N J Shaw; A M Weindling
Journal:  Acta Paediatr Scand       Date:  1990-10

3.  FACTORS INFLUENCING THE URINARY EXCRETION OF CALCIUM. I. IN NORMAL PERSONS.

Authors:  E L Knapp
Journal:  J Clin Invest       Date:  1947-03       Impact factor: 14.808

4.  Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population.

Authors:  V Matos; G van Melle; O Boulat; M Markert; C Bachmann; J P Guignard
Journal:  J Pediatr       Date:  1997-08       Impact factor: 4.406

5.  Renal excretion of calcium and phosphate in preterm and term infants.

Authors:  J Karlén; A Aperia; R Zetterström
Journal:  J Pediatr       Date:  1985-05       Impact factor: 4.406

6.  On the mechanisms of renal sodium handling in newborn infants.

Authors:  E Sulyok; F Varga; E Györy; K Jobst; I F Csaba
Journal:  Biol Neonate       Date:  1980

7.  Normal urinary calcium/creatinine ratios in African-American and Caucasian children.

Authors:  N P So; A V Osorio; S D Simon; U S Alon
Journal:  Pediatr Nephrol       Date:  2001-02       Impact factor: 3.714

8.  Incidence, ultrasonic patterns and resolution of nephrocalcinosis in very low birthweight infants.

Authors:  T Saarela; A Vaarala; P Lanning; M Koivisto
Journal:  Acta Paediatr       Date:  1999-06       Impact factor: 2.299

9.  Hypophosphatemia and hypercalciuria in small premature infants fed human milk: evidence for inadequate dietary phosphorus.

Authors:  J Rowe; D Rowe; E Horak; T Spackman; R Saltzman; S Robinson; A Philipps; J Raye
Journal:  J Pediatr       Date:  1984-01       Impact factor: 4.406

10.  Calcium and phosphorus balance in extremely low birthweight infants in the first six weeks of life.

Authors:  A J Lyon; N McIntosh
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

View more
  11 in total

1.  The effect of phototherapy on urinary calcium excretion in newborns.

Authors:  Nakisa Hooman; Ali Honarpisheh
Journal:  Pediatr Nephrol       Date:  2005-06-23       Impact factor: 3.714

2.  A randomized double-blind controlled trial comparing two regimens of vitamin D supplementation in preterm neonates.

Authors:  M Tergestina; G Rebekah; V Job; A Simon; N Thomas
Journal:  J Perinatol       Date:  2016-05-05       Impact factor: 2.521

3.  Neonatal nephrocalcinosis: long term follow up.

Authors:  E Porter; A McKie; T J Beattie; J H McColl; N Aladangady; A Watt; M P White
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-05-16       Impact factor: 5.747

4.  Evaluating Vitamin D Status in Infants Less than Seven Months; What Are the Preferred Biochemical Measurements?

Authors:  Grace G Pouch; Myla Ebeling; Judy R Shary; Bruce W Hollis; Cynthia R Howard; Carol L Wagner
Journal:  Breastfeed Med       Date:  2022-02-23       Impact factor: 2.335

5.  Changes in red cell phosphate metabolism of preterm and fullterm infants with perinatal problems during their first month of life.

Authors:  V Cholevas; A Challa; P D Lapatsanis; S Andronikou
Journal:  Eur J Pediatr       Date:  2007-04-26       Impact factor: 3.183

6.  Metabolic bone disease in the preterm infant: Current state and future directions.

Authors:  Moghis Ur Rehman; Hassib Narchi
Journal:  World J Methodol       Date:  2015-09-26

7.  Bone status in preterm infant: influences of different nutritional regimens and possible markers of bone disease.

Authors:  M Meneghelli; A Pasinato; S Salvadori; P Gaio; M Fantinato; V Vanzo; F De Terlizzi; G Verlato
Journal:  J Perinatol       Date:  2016-01-14       Impact factor: 2.521

Review 8.  Inside the "fragile" infant: pathophysiology, molecular background, risk factors and investigation of neonatal osteopenia.

Authors:  Charalampos Dokos; Christos Tsakalidis; Athanasios Tragiannidis; Dimitrios Rallis
Journal:  Clin Cases Miner Bone Metab       Date:  2013-05

9.  Changes in Biochemical Parameters of the Calcium-Phosphorus Homeostasis in Relation to Nutritional Intake in Very-Low-Birth-Weight Infants.

Authors:  Viola Christmann; Charlotte J W Gradussen; Michelle N Körnmann; Nel Roeleveld; Johannes B van Goudoever; Arno F J van Heijst
Journal:  Nutrients       Date:  2016-11-29       Impact factor: 5.717

10.  Postnatal Changes in Humerus Cortical Bone Thickness Reflect the Development of Metabolic Bone Disease in Preterm Infants.

Authors:  Shuko Tokuriki; Aiko Igarashi; Takashi Okuno; Genrei Ohta; Takuya Kosaka; Yusei Ohshima
Journal:  Dis Markers       Date:  2016-04-18       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.